Laman Utama7CA • FRA
add
Camurus AB
Tutup sebelumnya
€60.80
Julat hari
€61.05 - €61.05
Julat tahun
€41.28 - €62.60
Permodalan pasaran
39.13B SEK
Bilangan Purata
14.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
STO
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (SEK) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 553.13J | 47.67% |
Perbelanjaan pengendalian | 359.28J | -1.03% |
Pendapatan bersih | 146.98J | 1,066.60% |
Margin untung bersih | 26.57 | 754.43% |
Pendapatan bagi setiap syer | 2.45 | 1,007.41% |
EBITDA | 164.05J | 1,057.04% |
Kadar cukai berkesan | 21.08% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (SEK) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.85B | 139.75% |
Jumlah aset | 3.76B | 96.93% |
Jumlah liabiliti | 467.33J | 12.66% |
Jumlah ekuiti | 3.29B | — |
Syer tertunggak | 58.64J | — |
Harga kepada buku | 1.08 | — |
Pulangan pada aset | 10.96% | — |
Pulangan pada modal | 12.47% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (SEK) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 146.98J | 1,066.60% |
Tunai daripada operasi | 103.25J | 244.05% |
Tunai daripada pelaburan | -19.89J | -733.84% |
Tunai daripada pembiayaan | 15.43J | 36.67% |
Perubahan bersih dalam tunai | 101.44J | 181.88% |
Aliran tunai bebas | 28.06J | -66.00% |
Perihal
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Diasaskan
1991
Tapak web
Pekerja
247
